↓ Skip to main content

Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma.

Overview of attention for article published in Molecular Cancer Therapeutics, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma.
Published in
Molecular Cancer Therapeutics, September 2022
DOI 10.1158/1535-7163.mct-21-0991
Pubmed ID
Authors

Rutulkumar Patel, Yvonne M Mowery, Yi Qi, Alex M Bassil, Matt Holbrook, Eric S Xu, Cierra S Hong, Jonathon E Himes, Nerissa T Williams, Jeffrey Everitt, Yan Ma, Lixia Luo, Sara R Selitsky, Jennifer L Modliszewski, Junheng Gao, Sin-Ho Jung, David G Kirsch, Cristian T Badea

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2023.
All research outputs
#13,170,965
of 23,230,825 outputs
Outputs from Molecular Cancer Therapeutics
#2,702
of 3,889 outputs
Outputs of similar age
#161,947
of 438,992 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#13
of 38 outputs
Altmetric has tracked 23,230,825 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,889 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,992 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.